A comparison of AAV-vector production methods for gene therapy and preclinical assessment
Abstract Adeno Associated Virus (AAV)-mediated gene expression in the brain is widely applied in the preclinical setting to investigate the therapeutic potential of specific molecular targets, characterize various cellular functions, and model central nervous system (CNS) diseases. In therapeutic ap...
Guardado en:
Autores principales: | Marcus Davidsson, Matilde Negrini, Swantje Hauser, Alexander Svanbergsson, Marcus Lockowandt, Giuseppe Tomasello, Fredric P. Manfredsson, Andreas Heuer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74a1356fd99448379cbe95576b741883 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
AAV vector-mediated in vivo reprogramming into pluripotency
por: Elena Senís, et al.
Publicado: (2018) -
Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.
por: Patrick Aldrin-Kirk, et al.
Publicado: (2014) -
AAV2.7m8 is a powerful viral vector for inner ear gene therapy
por: Kevin Isgrig, et al.
Publicado: (2019) -
Polymers for improving the in vivo transduction efficiency of AAV2 vectors.
por: Gilles Moulay, et al.
Publicado: (2010) -
High levels of AAV vector integration into CRISPR-induced DNA breaks
por: Killian S. Hanlon, et al.
Publicado: (2019)